J. A. Andersen

956 total citations
9 papers, 651 citations indexed

About

J. A. Andersen is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, J. A. Andersen has authored 9 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 4 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in J. A. Andersen's work include Breast Cancer Treatment Studies (6 papers), Breast Lesions and Carcinomas (4 papers) and Cancer and Skin Lesions (2 papers). J. A. Andersen is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Breast Lesions and Carcinomas (4 papers) and Cancer and Skin Lesions (2 papers). J. A. Andersen collaborates with scholars based in Denmark, Norway and Sweden. J. A. Andersen's co-authors include Michael Bachmann Nielsen, U Dyreborg, M Blichert-Toft, H.T. Mouridsen, C. Sainte Rose, Marie Overgaard, Nikos Pandis, Sverre Heim, Manuel R. Teixeira and C. K. Axelsson and has published in prestigious journals such as Annals of Surgery, British Journal of Cancer and Acta Paediatrica.

In The Last Decade

J. A. Andersen

8 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. A. Andersen Denmark 5 472 300 285 150 100 9 651
Malcolm Beinfield United States 11 683 1.4× 274 0.9× 505 1.8× 265 1.8× 92 0.9× 14 765
Leela Elavathil Canada 14 435 0.9× 351 1.2× 252 0.9× 119 0.8× 44 0.4× 25 672
Pamela H. Craig United States 8 790 1.7× 370 1.2× 684 2.4× 248 1.7× 63 0.6× 10 965
Gaetano Cardona Italy 16 423 0.9× 452 1.5× 363 1.3× 195 1.3× 61 0.6× 34 783
George Papadatos Australia 8 360 0.8× 261 0.9× 168 0.6× 102 0.7× 41 0.4× 15 505
Jay R. Harris United States 12 913 1.9× 455 1.5× 639 2.2× 302 2.0× 128 1.3× 13 1.2k
A.H. Tulusan Germany 9 452 1.0× 387 1.3× 210 0.7× 96 0.6× 40 0.4× 22 637
F. O’Malley Canada 6 332 0.7× 223 0.7× 209 0.7× 136 0.9× 28 0.3× 9 476
Abram Recht United States 12 976 2.1× 399 1.3× 741 2.6× 276 1.8× 102 1.0× 15 1.1k
D Sarrazin France 7 350 0.7× 242 0.8× 235 0.8× 64 0.4× 42 0.4× 19 483

Countries citing papers authored by J. A. Andersen

Since Specialization
Citations

This map shows the geographic impact of J. A. Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. A. Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. A. Andersen more than expected).

Fields of papers citing papers by J. A. Andersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. A. Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. A. Andersen. The network helps show where J. A. Andersen may publish in the future.

Co-authorship network of co-authors of J. A. Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of J. A. Andersen. A scholar is included among the top collaborators of J. A. Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. A. Andersen. J. A. Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Teixeira, Manuel R., Nikos Pandis, J. A. Andersen, & Sverre Heim. (1996). Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. Cancer Genetics and Cytogenetics. 91(2). 124–124. 17 indexed citations
3.
Pandis, Nikos, Georgia Bardi, Inga Hägerstrand, et al.. (1995). REARRANGEMENT OF CHROMOSOMAL BANDS-3P13-14 IN 2 HAMARTOMAS OF THE BREAST. International Journal of Oncology. 6(3). 559–61. 3 indexed citations
4.
Blichert-Toft, M, et al.. (1992). Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group.. PubMed. 19–25. 296 indexed citations
5.
Rose, Carsten, J. A. Andersen, Knud Andersen, et al.. (1991). [Adjuvant endocrine treatment of postmenopausal patients with breast cancer with high risk of recurrence. 5. Results from the DBCG (Danish Breast Cancer Cooperative Group) 77C randomized trial].. PubMed. 153(33). 2283–7. 1 indexed citations
6.
Ottesen, Gyda Lolk, J. A. Andersen, M Blichert-Toft, & C. K. Axelsson. (1988). Frequency and Types of Chest Wall Recurrences Among Node Negative Breast Cancer Patients. Acta Oncologica. 27(6). 601–604. 12 indexed citations
7.
Nielsen, Michael Bachmann, et al.. (1987). Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. British Journal of Cancer. 56(6). 814–819. 296 indexed citations
8.
Nielsen, Michael Bachmann, Lise Christensen, U Dyreborg, & J. A. Andersen. (1987). Contributions to the Diagnosis of Contralateral Malignancies in Women with Invasive Breast Cancer. Recent results in cancer research. 105. 124–129. 2 indexed citations
9.
Andersen, J. A., K Hou-Jensen, Knud Andersen, et al.. (1981). Selection of High Risk Groups Among Prognostically Favorable Patients with Breast Cancer. Annals of Surgery. 194(1). 1???3–1???3. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026